NCBiotech understands the importance of emerging entrepreneurial companies to the state’s life science landscape.
Through the Emerging Company Development program, the Center invests in promising, emerging life science companies across the state.
These investments help recipients achieve meaningful research and commercial milestones. This, in turn, enables them to attract additional funding to fuel their growth. Historically, each dollar of NCBiotech investment has been followed by an average of $104 in follow-on funding. This funding includes government grants, angel and venture capital investments, IPOs, and strategic partnerships.
Emerging Company Investments
Supports business inception and research critical to developing products, processes, or tools with clear commercial potential. Award range: $100,000 to $250,000
Supplements Biotechnology Center investments with angel or venture capital investments to fund life science companies that have established technical proof-of-concept and require further support to accelerate growth. Award range: $250,000 to $500,000